ATA308986A - HUMAN MANGANESE SUPEROXIDE DISMUTASE CDNA, ITS EXPRESSION IN BACTERIA AND METHOD FOR OBTAINING ENZYMATICALLY ACTIVE, HUMAN MANGANESE SUPEROXIDE DISISMUTASE - Google Patents

HUMAN MANGANESE SUPEROXIDE DISMUTASE CDNA, ITS EXPRESSION IN BACTERIA AND METHOD FOR OBTAINING ENZYMATICALLY ACTIVE, HUMAN MANGANESE SUPEROXIDE DISISMUTASE

Info

Publication number
ATA308986A
ATA308986A AT0308986A AT308986A ATA308986A AT A308986 A ATA308986 A AT A308986A AT 0308986 A AT0308986 A AT 0308986A AT 308986 A AT308986 A AT 308986A AT A308986 A ATA308986 A AT A308986A
Authority
AT
Austria
Prior art keywords
manganese superoxide
human manganese
disismutase
bacteria
expression
Prior art date
Application number
AT0308986A
Other languages
German (de)
Other versions
AT400443B (en
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of ATA308986A publication Critical patent/ATA308986A/en
Application granted granted Critical
Publication of AT400443B publication Critical patent/AT400443B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT0308986A 1985-11-22 1986-11-19 HUMAN MANGANESE SUPEROXIDE DISMUTASE CDNA, ITS EXPRESSION IN BACTERIA AND METHOD FOR OBTAINING ENZYMATICALLY ACTIVE, HUMAN MANGANESE SUPEROXIDE DISISMUTASE AT400443B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (2)

Publication Number Publication Date
ATA308986A true ATA308986A (en) 1995-05-15
AT400443B AT400443B (en) 1995-12-27

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0308986A AT400443B (en) 1985-11-22 1986-11-19 HUMAN MANGANESE SUPEROXIDE DISMUTASE CDNA, ITS EXPRESSION IN BACTERIA AND METHOD FOR OBTAINING ENZYMATICALLY ACTIVE, HUMAN MANGANESE SUPEROXIDE DISISMUTASE

Country Status (21)

Country Link
JP (2) JP2609449B2 (en)
AT (1) AT400443B (en)
AU (1) AU607897B2 (en)
BE (1) BE905796A (en)
CA (1) CA1341362C (en)
CH (1) CH676990A5 (en)
DE (1) DE3639725C2 (en)
DK (1) DK534686A (en)
ES (1) ES2003518A6 (en)
FI (1) FI90353C (en)
FR (1) FR2590591B1 (en)
GB (1) GB2183658B (en)
GR (1) GR862713B (en)
HK (1) HK75195A (en)
IE (1) IE59498B1 (en)
IL (2) IL106449A (en)
IT (1) IT1205418B (en)
LU (1) LU86676A1 (en)
NL (1) NL8602960A (en)
PT (1) PT83792B (en)
SE (1) SE8604884L (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (en) * 1986-03-18 1987-09-22 Ube Ind Ltd anti-inflammatory agent
JPH0643341B2 (en) * 1986-03-27 1994-06-08 宇部興産株式会社 Organ function improving agent
JPH0643340B2 (en) * 1986-09-03 1994-06-08 宇部興産株式会社 Ischemic heart disease drug
JPS6377822A (en) * 1986-09-18 1988-04-08 Ube Ind Ltd Organ function improver
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
ES2083357T3 (en) * 1987-03-14 1996-04-16 Boehringer Ingelheim Int HUMAN MANGANESE-SUPEROXIDE-DISMUTASE (HMN-SOD).
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
DE3854678T2 (en) * 1987-03-27 1996-06-13 Bio Technology General Corp Human manganese superoxide dismutase and treatment procedure.
JPH01233228A (en) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd Metastasis preventive of malignant tumor cells
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (en) * 1990-12-04 1992-06-11 Gruenenthal Gmbh USE OF SUPEROXIDE DISMUTASES FOR PROPHYLAXIS AND / OR TREATMENT OF ORGAN FAILURE IN RISK PATIENTS WITH POLYTRAUMA
DE59310242D1 (en) * 1992-09-09 2002-01-17 Bio Technology General Corp Use of manganese superoxide dismutase (Mn-SOD) for the manufacture of medicaments for the treatment of diseases in low doses
DE4239877C1 (en) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilized superoxide dismutase (SOD) composition
WO2025178510A1 (en) * 2024-02-21 2025-08-28 Евгений Владимирович ГРИГОРЬЕВ Method of using superoxide dismutase 2 as an antioxidant in ultra-low doses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio- Technology General Corp METHOD FOR OBTAINING A POLYPEPTIDE WITH SUPEROXIDE DISMUTASE ACTIVITY
DE3486452T2 (en) * 1983-10-03 1997-11-06 Chiron Corp., Emeryville, Calif. Superoxide dismutase and its expression in microorganisms

Also Published As

Publication number Publication date
IL106449A (en) 1997-02-18
IL106449A0 (en) 1993-11-15
CH676990A5 (en) 1991-03-28
JP2609449B2 (en) 1997-05-14
SE8604884D0 (en) 1986-11-14
FI864756A7 (en) 1987-05-23
FR2590591B1 (en) 1989-12-01
SE8604884L (en) 1987-05-23
IT8667865A0 (en) 1986-11-21
DE3639725C2 (en) 1998-02-19
GB2183658A (en) 1987-06-10
GB8627294D0 (en) 1986-12-17
FI90353B (en) 1993-10-15
HK75195A (en) 1995-05-26
IE59498B1 (en) 1994-03-09
AT400443B (en) 1995-12-27
AU607897B2 (en) 1991-03-21
PT83792A (en) 1986-12-01
DK534686D0 (en) 1986-11-07
NL8602960A (en) 1987-06-16
PT83792B (en) 1989-01-17
JPS62289187A (en) 1987-12-16
CA1341362C (en) 2002-05-28
FI864756A0 (en) 1986-11-21
IE862851L (en) 1987-05-22
LU86676A1 (en) 1987-05-04
GB2183658B (en) 1990-04-25
GR862713B (en) 1987-03-24
DK534686A (en) 1987-05-23
FR2590591A1 (en) 1987-05-29
JP2967557B2 (en) 1999-10-25
IL80702A0 (en) 1987-02-27
FI90353C (en) 1994-01-25
JPH08289792A (en) 1996-11-05
IT1205418B (en) 1989-03-15
ES2003518A6 (en) 1988-11-01
AU6497586A (en) 1987-05-28
BE905796A (en) 1987-03-16
DE3639725A1 (en) 1987-07-23

Similar Documents

Publication Publication Date Title
ATE58543T1 (en) PROCESSES FOR THE SULPHATATION OF GLYCOSAMINOGLYCANS, GLYCOSAMINOGLYCANS MANUFACTURED THEREFROM AND THEIR BIOLOGICAL USES.
DE68911299D1 (en) ENZYME ELECTRODE AND PRODUCTION METHOD.
DE3682686D1 (en) ABSORBENT PART FOR TAMPON AND METHOD FOR THE PRODUCTION THEREOF.
DE3582523D1 (en) CONTAINER AND METHOD FOR STORING BLOOD.
FI851801A7 (en) Hydrogel bodies containing active substances and their preparation and use.
DE3776300D1 (en) GAS-TIGHT ACCUMULATOR AND METHOD FOR PRODUCING ITS ELECTRODE.
DE3687646D1 (en) BIOSENSOR AND THEIR PRODUCTION.
ATA903086A (en) DEVICE AND METHOD FOR THE AUTOMATIC PRODUCTION OF LIFE OR FOODSTUFF IN PIECE MADE OF DUG-LIKE SUBSTANCES
DE68920223D1 (en) Enzyme electrodes and their manufacture.
DE3673112D1 (en) ELECTRODES FOR USE IN ELECTROCHEMICAL PROCESSES AND PRODUCTION.
DE3689943D1 (en) Degraded tissue plasminogen activator species, pharmaceutical preparation, and method of making the same.
DE3676447D1 (en) COMPOSITION AND METHOD FOR DETERMINING THE PEROXIDIC ACTIVITY OF HAEMOGLOBIN.
DE3668430D1 (en) COMPOSITE BODY AND METHOD FOR THE PRODUCTION THEREOF.
PT85444A (en) RENIN-INHIBITING DI- AND TRIPEPTIDES METHOD FOR THE PRODUCTION THEREOF AND THEIR USE THEREOF
IL106449A0 (en) Human manganese superoxide dismutase cdna and its expression in bacteria,and method of recovering enzymatically active human manganese superoxide dismutase
DE3750779D1 (en) Enzyme sensor and method of making the same.
DE3682247D1 (en) DEVICE AND METHOD FOR PRODUCING GELED PEARLS OF MICROBIC CELLS OR ENZYMES.
DE3688168D1 (en) EPIDERMIS CELL EXTRACTS AND METHOD FOR IMPROVING WIND HEALING AND REGENERATING EPIDERMIS.
DE68922550D1 (en) Alcohol oxidase enzyme electrode and method for determining alcohol content.
DE3672272D1 (en) METHOD FOR DETERMINING SUPEROXIDE DISMUTASE ACTIVITY.
DE59404208D1 (en) Aqueous precious metal preparations and their use in the manufacture of precious metal decorations
DE3674585D1 (en) PREPARATION FOR TREATING AND PREVENTING DIARRHOEE IN HUMAN AND ANIMALS AND METHOD FOR THE PRODUCTION THEREOF.
DE3670289D1 (en) METHOD FOR THE PRODUCTION OF ARYL-GLYCIDYL ETHERS AND OF 3-SUBSTITUTED 1-ALKYLAMINO-2-PROPANOLS.
DE69017782D1 (en) Sodium sulfur cell and method of making the same.
DE68907840D1 (en) METHOD FOR THE CATALYTIC PRODUCTION OF N-SUBSTITUTED ACRYLAMIDES AND METHACRYLAMIDES.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee